Perkinelmer, Inc.

+3.60 (+2.67%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)17.97B
Current PE27.51
Forward PE 17.81
2yr Forward PE 25.75
See more stats
Estimates Current Quarter
Revenue$1.03 Billion
Adjusted EPS$1.62
See more estimates
10-Day MA$136.09
50-Day MA$138.02
200-Day MA$140.11
See more pivots

Perkinelmer, Inc. Stock, NYSE:PKI

940 Winter Street, Waltham, Massachusetts 02451
United States of America
Phone: +1.781.663.6900
Number of Employees: 16700


PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment consists of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.